These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Maternal dietary antigen avoidance during pregnancy or lactation, or both, for preventing or treating atopic disease in the child. Kramer MS; Kakuma R Cochrane Database Syst Rev; 2012 Sep; 2012(9):CD000133. PubMed ID: 22972039 [TBL] [Abstract][Full Text] [Related]
23. Immune-related microRNAs in breast milk and their relation to regulatory T cells in breastfed children. Ahlberg E; Martí M; Govindaraj D; Severin E; Duchén K; Jenmalm MC; Tingö L Pediatr Allergy Immunol; 2023 Apr; 34(4):e13952. PubMed ID: 37102392 [TBL] [Abstract][Full Text] [Related]
25. Probiotics to prevent infantile colic. Ong TG; Gordon M; Banks SS; Thomas MR; Akobeng AK Cochrane Database Syst Rev; 2019 Mar; 3(3):CD012473. PubMed ID: 30865287 [TBL] [Abstract][Full Text] [Related]
26. Crying Time and RORγ/FOXP3 Expression in Lactobacillus reuteri DSM17938-Treated Infants with Colic: A Randomized Trial. Savino F; Garro M; Montanari P; Galliano I; Bergallo M J Pediatr; 2018 Jan; 192():171-177.e1. PubMed ID: 28969887 [TBL] [Abstract][Full Text] [Related]
27. Oropharyngeal administration of mother's colostrum, health outcomes of premature infants: study protocol for a randomized controlled trial. Rodriguez NA; Vento M; Claud EC; Wang CE; Caplan MS Trials; 2015 Oct; 16():453. PubMed ID: 26458907 [TBL] [Abstract][Full Text] [Related]
28. Administration of a Multi-Strain Probiotic Product to Women in the Perinatal Period Differentially Affects the Breast Milk Cytokine Profile and May Have Beneficial Effects on Neonatal Gastrointestinal Functional Symptoms. A Randomized Clinical Trial. Baldassarre ME; Di Mauro A; Mastromarino P; Fanelli M; Martinelli D; Urbano F; Capobianco D; Laforgia N Nutrients; 2016 Oct; 8(11):. PubMed ID: 27801789 [TBL] [Abstract][Full Text] [Related]
29. Maternal dietary antigen avoidance during pregnancy or lactation, or both, for preventing or treating atopic disease in the child. Kramer MS; Kakuma R Evid Based Child Health; 2014 Jun; 9(2):447-83. PubMed ID: 25404609 [TBL] [Abstract][Full Text] [Related]
30. Pre- and postnatal Lactobacillus reuteri treatment alters DNA methylation of infant T helper cells. Forsberg A; Huoman J; Söderholm S; Bhai Mehta R; Nilsson L; Abrahamsson TR; Ernerudh J; Gustafsson M; Jenmalm MC Pediatr Allergy Immunol; 2020 Jul; 31(5):544-553. PubMed ID: 32150651 [TBL] [Abstract][Full Text] [Related]
31. Effectiveness of Lactobacillus reuteri in infantile colic and colicky induced maternal depression: a prospective single blind randomized trial. Mi GL; Zhao L; Qiao DD; Kang WQ; Tang MQ; Xu JK Antonie Van Leeuwenhoek; 2015 Jun; 107(6):1547-53. PubMed ID: 25876529 [TBL] [Abstract][Full Text] [Related]
32. Atopic dermatitis prevention in children following maternal probiotic supplementation does not appear to be mediated by breast milk TSLP or TGF-β. Simpson MR; Rø AD; Grimstad Ø; Johnsen R; Storrø O; Øien T Clin Transl Allergy; 2016; 6():27. PubMed ID: 27453775 [TBL] [Abstract][Full Text] [Related]
33. Regulatory T cells and Toll-like receptor 2 and 4 mRNA expression in infants with colic treated with Savino F; Galliano I; Garro M; Savino A; Daprà V; Montanari P; Bergallo M Benef Microbes; 2018 Dec; 9(6):917-925. PubMed ID: 30406696 [TBL] [Abstract][Full Text] [Related]
34. Limosilactobacillus reuteri SLZX19-12 Protects the Colon from Infection by Enhancing Stability of the Gut Microbiota and Barrier Integrity and Reducing Inflammation. Wu J; Lin Z; Wang X; Zhao Y; Zhao J; Liu H; Johnston LJ; Lu L; Ma X Microbiol Spectr; 2022 Jun; 10(3):e0212421. PubMed ID: 35658572 [TBL] [Abstract][Full Text] [Related]
35. Genomic, phenotypic, and clinical safety of Limosilactobacillus reuteri ATCC PTA 4659. Sendelius M; Axelsson J; Liu P; Roos S J Ind Microbiol Biotechnol; 2023 Feb; 50(1):. PubMed ID: 37974056 [TBL] [Abstract][Full Text] [Related]
36. Luo Z; Chen A; Xie A; Liu X; Jiang S; Yu R Front Immunol; 2023; 14():1228754. PubMed ID: 37638038 [TBL] [Abstract][Full Text] [Related]
37. Effectiveness of an antenatal maternal supplementation with prebiotics for preventing atopic dermatitis in high-risk children (the PREGRALL study): protocol for a randomised controlled trial. Cabridain C; Aubert H; Kaeffer B; Badon V; Boivin M; Dochez V; Winer N; Faurel-Paul E; Planche L; Riochet D; Maruani A; Perrotin F; Droitcourt C; Lassel L; Tching-Sin M; Rogers NK; Bodinier M; Barbarot S BMJ Open; 2019 Apr; 9(4):e024974. PubMed ID: 31005913 [TBL] [Abstract][Full Text] [Related]
38. Metabolic effects of Lactobacillus reuteri DSM 17938 in people with type 2 diabetes: A randomized controlled trial. Mobini R; Tremaroli V; Ståhlman M; Karlsson F; Levin M; Ljungberg M; Sohlin M; Bertéus Forslund H; Perkins R; Bäckhed F; Jansson PA Diabetes Obes Metab; 2017 Apr; 19(4):579-589. PubMed ID: 28009106 [TBL] [Abstract][Full Text] [Related]
39. Perinatal probiotic supplementation in the prevention of allergy related disease: 6 year follow up of a randomised controlled trial. Simpson MR; Dotterud CK; Storrø O; Johnsen R; Øien T BMC Dermatol; 2015 Aug; 15():13. PubMed ID: 26232126 [TBL] [Abstract][Full Text] [Related]
40. A randomized, double-blind, placebo-controlled phase III clinical trial to evaluate the efficacy and safety of SARS-CoV-2 vaccine (inactivated, Vero cell): a structured summary of a study protocol for a randomised controlled trial. Akova M; Unal S Trials; 2021 Apr; 22(1):276. PubMed ID: 33849629 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]